Ensign Peak Advisors
KALA icon

Ensign Peak Advisors’s KALA BIO KALA Stock Holding History

Ensign Peak Advisors’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18
Closed -$244K – 1864
2021
Q2 		$244K Sell
18
-30
-63% -$472K ﹤0.01% 1699
2021
Q1 		$811K Hold
48
– – ﹤0.01% 1488
2020
Q4 		$815K Sell
48
-8
-14% -$151K ﹤0.01% 1480
2020
Q3 		$1.05M Sell
56
-74
-57% -$1.7M ﹤0.01% 1294
2020
Q2 		$3.42M Buy
130
+40
+44% +$1.13M 0.01% 725
2020
Q1 		$1.97M Buy
+90
New +$1.44M 0.01% 835

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Ensign Peak Advisors's KALA Position: Q3 2021 in Review

Ensign Peak Advisors sold out of KALA BIO (KALA) in Q3 2021, closing a stake of 18 shares — an estimated $244K sold.

Ensign Peak Advisors first reported a position in KALA in Q1 2020 and held it in 6 quarters. The position peaked at $3.42M in Q2 2020. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Ensign Peak Advisors reported no remaining KALA BIO position as of Q3 2021 after selling out during the quarter.
  • Ensign Peak Advisors sold 18 KALA BIO shares in Q3 2021, an estimated $244K.
  • Ensign Peak Advisors first reported a position in KALA BIO in Q1 2020 and held it in 6 quarters.
  • Ensign Peak Advisors's KALA BIO position peaked at $3.42M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.